These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27088406)

  • 1. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
    Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J
    Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
    Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
    Li C; Li T; Huang L; Yang M; Zhu G
    Chem Asian J; 2019 May; 14(9):1570-1576. PubMed ID: 30843348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A micellar cisplatin prodrug simultaneously eliminates both cancer cells and cancer stem cells in lung cancer.
    Zhu YH; Sun CY; Shen S; Khan MIU; Zhao YY; Liu Y; Wang YC; Wang J
    Biomater Sci; 2017 Jul; 5(8):1612-1621. PubMed ID: 28580971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
    Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
    ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy.
    Wang JL; Gan YJ; Iqbal S; Jiang W; Yuan YY; Wang J
    Biomater Sci; 2018 Jun; 6(7):1916-1922. PubMed ID: 29850666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning Ineffective Transplatin into a Highly Potent Anticancer Drug via a Prodrug Strategy for Drug Delivery and Inhibiting Cisplatin Drug Resistance.
    Li W; Jiang M; Cao Y; Yan L; Qi R; Li Y; Jing X
    Bioconjug Chem; 2016 Aug; 27(8):1802-6. PubMed ID: 27380489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
    Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
    J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
    Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
    Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
    Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.
    Surnar B; Sharma K; Jayakannan M
    Nanoscale; 2015 Nov; 7(42):17964-79. PubMed ID: 26465291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer.
    Wan J; Huang L; Cheng J; Qi H; Jin J; Wang H
    Theranostics; 2021; 11(9):4137-4154. PubMed ID: 33754053
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer.
    Lu H; Tong W; Jiang M; Liu H; Meng C; Wang K; Mu X
    ACS Nano; 2024 Aug; 18(32):21156-21170. PubMed ID: 39088743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform.
    Liang Z; Li J; Zhu B
    Drug Des Devel Ther; 2020; 14():4519-4531. PubMed ID: 33149550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.